Tibet Duo Rui Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Tibet Duo Rui Pharmaceutical has a total shareholder equity of CN¥799.2M and total debt of CN¥274.8M, which brings its debt-to-equity ratio to 34.4%. Its total assets and total liabilities are CN¥1.1B and CN¥317.2M respectively.
Key information
34.4%
Debt to equity ratio
CN¥274.76m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥513.29m |
| Equity | CN¥799.18m |
| Total liabilities | CN¥317.25m |
| Total assets | CN¥1.12b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301075's short term assets (CN¥682.4M) exceed its short term liabilities (CN¥125.7M).
Long Term Liabilities: 301075's short term assets (CN¥682.4M) exceed its long term liabilities (CN¥191.5M).
Debt to Equity History and Analysis
Debt Level: 301075 has more cash than its total debt.
Reducing Debt: 301075's debt to equity ratio has increased from 9.3% to 34.4% over the past 5 years.
Debt Coverage: 301075's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 301075's interest payments on its debt are well covered by EBIT.